bpc 157 risks FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list Exciting news for peptides coming

If the peptide restrictions are reversed through formal FDA rulemaking, compounding pharmacies would be legally allowed to prepare those peptides, but only as traditional, patient-specific compounded drugs, not as mass-market or FDA-approved therapies. If the peptides are formally added to the 503A bulk list, he says, pharmacies would have to follow the traditional 503A compounding rules

BPC-157 has been found to inhibit angiogenesis by using blood vessels, suppressing the production of pro-angiogenic factors and promoting the release of anti-angiogenic factors

We look at where you can get them, how much you need, if supplementing is necessary, and tips for incorporating them into your plant-based diet

Also, repeated convictions will increase your insurance costs (SR-22)